Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Tamoxifen: No Mortality Benefit For Most “High Risk” Women
This article is from
The Cancer Letter
archive.
Vol. 29 No. 9 | September 29, 2006
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Hawaiian Have Highest Cancer Rate In U.S.
April 29, 1983
TCL Archive
Acupuncture Can Relieve Side Effects of Hormone Treatment
April 29, 2011
TCL Archive
AACR, ASCO Continue Growth, Drop Idea Of “Cancer Week”
July 1, 1988
TCL Archive
40 Years Later: Doctor and Patient Reflect on the Cure
October 24, 2014
TCL Archive
Radiology Advocated As First Diagnostic Test After Hemoccult
April 25, 1986
TCL Archive
CCOP Summary Statements Soon To Be Available
April 22, 1983